The synthesis of protein A in Staphylococcus aureus is regulated by global regulatory loci such as sar and agr. Phenotypic data indicate that both sar and agr suppress protein A synthesis; like agr, sar also regulates protein A production at the transcriptional level. To determine the genetic requirement of sar in protein A suppression, we transformed shuttle plasmids containing various sar fragments into a sar mutant. Our results indicated that the 560-bp sarA transcript, or, more probably, the SarA protein (13.5 kDa), is sufficient for suppressing protein A gene transcription when introduced on a multicopy plasmid or as a single copy in the chromosome. Immunoblot analysis with a chicken anti-protein A antibody also confirmed the reduction in protein A expression in these sar mutant clones. Complementation studies revealed that the transcription of the protein A gene can be suppressed in a sar mutant background by a plasmid containing RNAIII. Surprisingly, in agr deletion mutant clones and in clones derived from the agr-sar double mutant, protein A gene transcription can also be suppressed by plasmids containing the sarA transcript plus additional upstream sequence but not the sarA transcript alone. These data suggest that the sar locus can down-modulate protein A gene transcription via both RNAIII-dependent and RNAIII-independent pathways. Consistent with the hypothesis of an RNAIIIindependent pathway is an additional genetic requirement for protein A suppression in the agr deletion mutant RN6911 as well as the isogenic double sar-agr mutant, whereas in the sar mutant background, the sarA transcript encoding the SarA protein alone is sufficient. These data suggested that both sar and agr are coregulators of protein A synthesis in S. aureus.
Protein A (SpA) is a major surface protein that is present in over 90% of Staphylococcus aureus strains (10, 27) . SpA makes up about 7% of the S. aureus cell wall (12) . Based on its immunoglobulin G (IgG)-binding property, it has been estimated that there are ϳ80,000 IgG-binding sites per cell in S. aureus Cowan 1 (18) . Although the molecular mass of Cowan 1 SpA has been estimated to be 42 kDa (3) , immunological analysis suggested that size heterogeneity in SpA exists among serologically distinct strains (5) . Besides being an integral cell wall protein, SpA is actively secreted into the supernatant of actively growing cultures. SpA is best studied for its interesting immunological properties. For instance, it can activate complement in vitro (11) . Additionally, the IgG-binding property of this protein has been exploited extensively in a variety of immunological assays (13) .
The biological properties of SpA have been extensively studied (10) . In vitro assays demonstrated that S. aureus strains with high SpA content are more resistant to phagocytosis than are strains with less SpA (25) . Presumably, the antiphagocytic effect may be mediated by the binding of SpA to the Fc portion of IgG, thus competing with phagocytic cells for available IgG-Fc sites and thereby resulting in diminished IgG-mediated opsonization (25) . Similarly, Greenberg et al. (14) found that hyperimmune serum to Cowan 1 SpA was associated with highly efficient opsonophagocytosis and killing of the homologous strain. However, the precise biological function of SpA in vivo remains poorly defined.
As a surface protein, SpA has been shown to be regulated by at least two distinct global regulatory loci, agr and sar (15, 17) . The agr locus is composed of two divergent transcripts, RNAII and RNAIII, which include at least five genes (agrA, agrB, agrC, agrD, and hld). Inactivation of the agr locus has led to increased synthesis of SpA. As RNAIII is the agr regulatory molecule ultimately responsible for the expression of the Agr ϩ phenotype during the postexponential growth phase (1, 22) , it is likely that RNAIII acts to suppress SpA gene transcription during this part of the growth cycle (23, 26) .
We recently described another regulatory locus, designated sar, which is also involved in the pleiotropic expression of both extracellular and cell wall proteins (8) . Transcriptional analysis revealed that the sar locus is composed of three overlapping transcripts, designated sarA, sarC, and sarB (sizing at 0.58, 0.84, and 1.15 kb, respectively) (2) . These three transcripts terminate in a common 3Ј end but originate from three distinct promoters (2) . Complementation analysis indicated that one of the genes (sarA, loc-on the 0.58-kb transcript) within the sar locus appears to be necessary for the optimal expression of RNAIII in the agr locus (2, 14, 15) . Like agr, the sar locus also suppresses SpA synthesis (8, 15) . However, the pathway by which the sar locus down-modulates the expression of SpA has not been previously defined.
We report here that the transcription of the SpA gene is coregulated by sar and agr. More specifically, the suppression of SpA by the sar locus can occur via both agr (RNAIII)-dependent and agr-independent pathways. Either of these pathways alone, if active, is sufficient for repression. In addition, the genetic requirement for down-modulating SpA gene transcription in a sar mutant background differs from that of the agr mutant background.
MATERIALS AND METHODS
Bacterial strains, plasmids, and phage. The bacterial strains and plasmids used in this study are listed in Table 1 . Phage 11 was used as a transducing phage for sar and agr mutants.
Media and antibiotics. CYGP and 0.3GL media (21) were used for the growth of S. aureus, while Luria-Bertani broth was used for the growth of Escherichia coli. Antibiotics were used at the following concentrations: erythromycin, 10 g/ml; tetracycline, 5 g/ml; ampicillin, 50 g/ml.
Cloning and sequencing strategies. DNA fragments encompassing the sar locus ( Fig. 1) were amplified by PCR with genomic DNA of S. aureus RN6390 as the template and cloned into the TA cloning vector pCRII (Invitrogen, San Diego, Calif.). The authenticity of the amplified fragments was confirmed by DNA sequencing. The PCR fragments were cleaved from pCRII, ligated to the shuttle vector pSPT181 or pSK236, and transformed into E. coli XL-1 Blue. The presence of the correct inserts in the plasmids was confirmed by restriction mapping and sequencing.
Genetic manipulations in S. aureus. Protoplast transformation of S. aureus RN4220 with shuttle plasmids containing various sar fragments was performed as previously described (8) . For transduction, phage 11 was used to produce a phage lysate of strain RN4220 containing recombinant shuttle vectors (pSPT181 or pSK236) with sar DNA fragments. The phage lysate was then used to infect either agr mutants (transposon mutant RN6112 or deletion mutant RN6911) or sar mutants (transposon sar mutant ALC136 [previously designated mutant R] or sar insertion mutant ALC488) as described previously (8) ( Table 1) .
The sar insertion mutant ALC488 was constructed by allele replacement from the temperature-sensitive shuttle plasmid pSPT181 containing the sarA gene into This study pSPT181 containing the sarA and sarC transcripts pALC861
This study pSK236 containing the sarA and sarC transcripts pALC862
This study pSK236 encompassing the sarA, sarC, and sarB transcriptional units pALC888
This study pSK236 with the sarA transcript plus 189 bp upstream but lacking the promoter for sarC (nucleotides 531 to 1349)
which an ermC gene has been inserted via the internal EcoRI site of the sarA coding region. Following transformation into RN4220, the recombinant plasmid was transduced into strain RN6390. The isolate containing the recombinant shuttle plasmid was maintained at 30°C with erythromycin and tetracycline, diluted 1:2,000 in CYGP medium containing erythromycin, and grown at 43°C for 18 h. Growth at the higher temperature was repeated three times to promote loss of plasmid, and the bacteria were plated on blood agar plates to select for nonhemolytic (i.e., sar mutant) and tetracycline-sensitive colonies. One isolated clone (ALC488) was confirmed by Southern blot analysis to have the correct chromosomal insertion. Northern blot analysis with a sarA probe also verified the disruption of all three sar transcripts (data not shown).
To introduce a single copy of the sar fragment into the chromosome of sar mutant ALC136, we cleaved from pBluescript phagemid a sar fragment which was then cloned into the PstI-SalI site of the integration vector pCL84 (19) . This vector inserts preferentially into the lipase gene of the staphylococcal chromosome. Following transformation into a derivative of RN4220 which supplies the integrase gene in trans, the integrants were selected on DM3 agar (8) with tetracycline at 3 g/ml. Loss of lipase activity in the transformants was confirmed by unique halo formation on egg yolk agar (19) . The integrated fragment was transduced into the sar mutant ALC136 with selection for tetracycline and loss of lipase activity. Correct integration was verified by Southern blots with lipase geneand sar-specific probes.
Immunoblot analysis of SpA. To determine levels of SpA production, cell wall-associated proteins were extracted from overnight cultures of S. aureus with lysostaphin in a hypertonic medium (30% raffinose) as previously described (7). Equal volumes of extracellular fluid from cells grown to the postexponential phase were harvested and concentrated 50-fold as described previously (8) .
Equivalent volumes (1 l each) of either extracellular or cell wall proteins were separated on sodium dodecyl sulfate-10% polyacrylamide gels. Separated proteins were electrophoretically blotted to nitrocellulose and probed with chicken anti-staphylococcal SpA antibody (Accurate Chemicals, Westbury, N.Y.) at a 1:3,000 dilution. Bound antibody was detected with rabbit anti-chicken IgG conjugated to alkaline phosphatase (Jackson Immunoresearch, West Grove, Pa.) (1:5,000 dilution) and visualized as described previously (4) .
Isolation of RNA and Northern analysis. Overnight cultures of S. aureus were diluted 1:100 in CYPG medium and grown to mid-log, late log, and postexponential phases. The cells were pelleted and processed with the FastRNA isolation kit (Bio101, Vista, Calif.) in combination with 0.1-mm-diameter zirconia/silica beads and a FastPrep reciprocating shaker (Bio101) as described previously (6 (Table 1) was radiolabeled with [␣-32 P]dCTP (Amersham) by the random prime method (Ready to Go Labeling Kit; Pharmacia, Piscataway, N.J.) and hybridized under high-stringency conditions. The blots were subsequently autoradiographed.
RESULTS
Regulation of SpA gene transcription by the sar locus. In a previous study, we have shown that a shuttle plasmid carrying the sarA gene partially restored the defect in hemolysin production to a transposon-mediated sar mutant while a larger (1.3-kb) fragment encompassing all three transcripts of the sar locus was able to completely reestablish the parental phenotype (2) . In addition, the synthesis of SpA as determined by immunoblotting was increased in the sar mutant but returned to the parental level upon the introduction of a shuttle plasmid carrying all three sar transcripts. To ascertain the mode of SpA control by the sar locus, we have chosen to evaluate SpA expression in strain RN6390 because this strain, being a low producer of SpA, show increased sensitivity in the detection of SpA suppression when compared with an isogenic sar mutant that overexpresses SpA (15, 21) . After transforming various DNA fragments containing either part or all of the sar locus into the isogenic sar mutant (Fig. 1) , we assayed for SpA production as determined by Northern and Western blot analysis.
Northern blot analysis revealed that the transcription of the SpA gene was markedly increased in the sar mutant as compared to the parental strain, which exhibited a very low level of the SpA gene transcript (Fig. 1) . Upon introduction of a shuttle plasmid comprising the smallest transcript (sarA in ALC103), the transcription of the SpA gene in the mutant decreased to the parental level. Complementation studies with plasmids containing DNA fragments that encompassed two additional sar transcriptional units (sarB and sarC) revealed that the SpA gene transcript remained depressed at the parental level. In contrast, a sar mutant clone transformed with a plasmid containing only a fragment upstream of sarA (pALC406) exhibited an elevated SpA gene transcript level similar to that produced by the sar mutant ALC136 alone (data not shown). To assess the role of the sarA gene product in SpA suppression, a series of 3Ј sar deletion clones lacking a part or all of the 339-bp sarA open reading frame (ORF) derived from RN6390 were constructed. Remarkably, each of these 3Ј sar deletion clones displayed a high level of SpA gene transcription analogous to the sar mutant (data not shown), thus suggesting that the sarA gene product is critical to the control of SpA gene transcription.
We compared the expression of SpA in cell wall extracts of these sar mutant clones on immunoblots. As anticipated, the synthesis of cell wall-associated SpA, as detected by using affinitypurified chicken anti-SpA antibody, was markedly enhanced in the sar mutant (2) when compared to the parent (Fig. 2) . By analogy to the transcriptional data, the expression of SpA in cell FIG. 1. Northern blot of sar mutant clones probed with an 800-bp spa fragment. RNA was obtained from cells harvested at the late log phase. sar mutant strains have the following designations: ALC136 is the transposon-mediated sar mutant; ALC103, ALC557, and ALC70 are sar mutant clones derived from ALC136 carrying recombinant shuttle plasmids pALC103, pALC557, and pALC70, respectively. Plasmids pALC103, pALC557, and pALC70 contain the sarA transcript, sarA and sarC transcripts, and sarA, sarC, and sarB transcripts, respectively. The numbers adjacent to the promoter boxes above correspond to the transcription start sites and are expressed as the number of nucleotides upstream of the sarA translation start. The double mutant was constructed by transducing the sar mutation into the agr mutant RN6911. wall extracts of sar mutant clones expressing sarA, sarB, or sarC transcriptional units was also reduced to parental levels. In contrast, clones containing fragments either upstream or downstream of the sar locus expressed SpA levels similar to that of the sar mutant alone (data not shown). We obtained similar results when we assayed for relative extracellular SpA levels in culture supernatants from these sar clones (data not shown).
To avoid the gene dosage problem associated with multicopy plasmids, we introduced a single copy of the fragment encoding the sarA transcript into the sar mutant via the integration vector pCL84, which preferentially inserts into the lipase gene of the staphylococcal chromosome. Northern blot analysis revealed that the transcription of the SpA gene in the integrant containing a single copy of sarA was reduced to near the parental level (Fig. 3) while the sar mutant clone containing only the integration vector pCL84 (ALC599 in Fig. 3 ) exhibited a high SpA gene transcript level that was slightly lower than that of the sar mutant alone. The reason for this slight reduction is not clear, because inactivation of the lipase gene has not been previously shown to affect SpA gene transcription (18a). Immunoblot studies with the cell wall extract of the clone containing a single copy of sarA also confirmed the down-regulation in SpA expression to the parental level (data not shown).
Suppression of SpA gene transcription in sar and agr mutants. As both sar and agr repress SpA expression (15), we wanted to determine if the increase in SpA gene transcription in a sar mutant was mediated by RNAIII and/or other agrindependent but sar-specific pathways. We first examined if SpA gene transcription can be suppressed in a sar mutant by a plasmid containing the agr regulatory molecule RNAIII. Using plasmid pRN6735, which contains a cloned RNAIII fragment under the control of a ␤-lactamase promoter (22), we were able to show that the transcription of the SpA gene was suppressed in a sar mutant clone (ALC184) carrying this plasmid (Fig. 4) . As expected, RNAIII was expressed at a higher level in this clone than in the sar mutant ALC136 (data not shown). Immunoblot analysis of the cell wall extract also confirmed a reduction in SpA expression in strain ALC184 (data not shown).
To assess the agr-independent mechanism in SpA expression, an agr mutant, RN6911, with the agr fragment, encoding both RNAII and RNAIII replaced by a tetM gene (22) , was transformed with shuttle plasmid pSK236 containing all three sar transcripts. As predicted, the basal SpA gene transcription level was higher in the agr mutant than in the parental strain, RN6390 (Fig.  5) . Surprisingly, the introduction of a 1.7-kb fragment encompassing all three sar transcripts into the agr mutant RN6911 yielded a parental level of SpA gene transcription (clone ALC865 in Fig. 5 ). Parental levels of SpA were also observed in the cell wall and extracellular fractions of the agr mutant clone containing this sar fragment (data not shown). Similar down-regulation in SpA expression was obtained when the plasmid (pALC862) containing all three sar transcripts was transformed into Tn551-mediated agr mutant RN6112. This mutant, with a transposon insertion in agrA (1), also lacked RNAIII transcription as determined by Northern blot analysis (data not shown).
To further assess the role of sar in the control of SpA expression, we assayed for SpA gene transcription in the double mutant ALC842 lacking both RNAIII and sar-related transcriptions. As expected, SpA gene transcription was not repressed in this genetic background (Fig. 6) . However, upon the introduction of a fragment containing all three sar transcripts into the double mutant via the shuttle plasmid pSK236, the repression in SpA gene transcription was reestablished (ALC870 in Fig. 6 ). These data, together with those seen with agr mutant RN6911, imply an additional mechanism independent of RNAIII that is responsible for the down-modulation of SpA expression by the sar locus. The genetic requirement of the sar locus in SpA suppression in an agr mutant background. To determine the sar genetic requirement in the suppression of SpA gene transcription, we transformed shuttle plasmids (pALC213, pALC888, pALC861, and pALC862) containing progressively longer sar fragments into agr mutant RN6911 to yield ALC863, ALC890, ALC864, and ALC865, respectively. Plasmids containing similar sar fragments were also introduced into Tn551-mediated agr mutant RN6112 (Table 1) . Northern blot analysis revealed that the sar-related transcripts were transcribed efficiently in these genetic backgrounds (data not shown). In contrast to the finding of an agr mutant clone containing a plasmid with all three sar transcripts (ALC865), a clone with a similar genetic background (ALC863) carrying a fragment containing the sarA transcript alone was not successful in suppressing SpA gene transcription (Fig. 5) . Surprisingly, an agr mutant clone (ALC890) comprising the sarA transcript plus an additional 189-bp upstream sequence (but lacking the sarC-specific P3 promoter) down-modulated SpA gene transcription successfully. As anticipated, sar fragments larger than that in pALC888 also repressed SpA gene transcription. Thus, the minimum sar genetic requirement for suppressing SpA gene transcription in the RN6911-derived agr mutant background appears to require the gene products derived from the sarA transcript plus an additional upstream fragment. A similar genetic requirement was also observed in the transposon agr mutant RN6112 (data not shown).
As an additional confirmation of this genetic requirement, we transformed shuttle plasmids encoding various sar fragments into the double mutant (ALC842). As seen in Fig. 6 , only fragments containing the sarA transcript plus additional upstream sequence was able to repress SpA gene transcription in this mutant (ALC891) while the shuttle plasmid encompassing the sarA gene product alone had no effect (ALC868).
Genetic evidence that the sar transcripts are not regulated by agr. Given the surprising finding that the sar gene products were capable of reverting SpA gene transcription to the parental level in an agr mutant, we wanted to evaluate if the agr locus controls SpA gene transcription via sar. For this purpose, we analyzed sar-related transcription in an isogenic pair of agr strains in a Northern blot with a 732-bp sarA probe. As shown in Fig. 7 , the sar transcript levels were identical between the agr mutant and its isogenic parent at all phases of the growth cycle, thus confirming that the sar transcripts are not regulated by the agr locus. Northern blot analysis of an isogenic agr strain (RN6112) probed with a 732-bp sarA fragment contained within plasmid pALC103 (Fig. 1) . The optical densities at 650 nm (OD) of 0.7, 1.0, and 1.7 correspond to RNA obtained from cells harvested at the mid-log, late log, and stationary phases, respectively. Similar results were obtained with agr deletion mutant RN6911.
DISCUSSION
Expression of SpA, a major cell wall constituent of S. aureus, is apparently under the control of global regulatory loci such as sar and agr (15, 23) . Phenotypic analysis suggests that sar, like agr, acts to repress SpA expression. Consequently, inactivation of the sar locus has led to a derepression in SpA synthesis. As in agr, repression of SpA synthesis by the sar locus occurs primarily at the transcriptional level. Transcriptional analysis revealed that the sar locus is composed of three overlapping transcripts that are initiated from a parallel multiple promoter system (2). To determine the genetic requirement of the sar locus for SpA suppression, we transformed DNA fragments containing one or more of the sar transcriptional units into a sar mutant. Our results indicated that a shuttle plasmid carrying a fragment that encoded the 560-bp sarA transcript alone was sufficient to repress SpA gene transcription in the sar mutant. More importantly, the introduction of the sarA transcript as a single copy into the lipase gene of the host chromosome via the integration vector pCL84 demonstrated that the effect of SpA suppression by the sarA gene product was not attributable to an increased gene dosage as a result of the plasmid multicopy effect. As the sarA transcript in strain RN6390 encodes a 339-bp sarA gene product, we speculate that the SarA protein is absolutely necessary for this mode of SpA suppression because 3Ј deletion clones lacking the sarA ORF were incapable of repressing SpA gene transcription. In addition, the introduction of multiple stop codons into the amino terminus-encoding portion of the sarA gene by site-directed mutagenesis abolished the ability of the sarA gene to repress SpA gene transcription even when the mutated sarA mRNA was appropriately transcribed (unpublished data). This notion contrasts with the agr system, in which the regulatory molecule controlling exoprotein synthesis is believed to be the RNAIII transcript itself rather than its translated product (16, 22) .
To assess the role of sar and agr in controlling SpA gene transcription, we first transformed a DNA fragment containing RNAIII into the sar mutant. A plasmid (pRN6735) containing the agr regulatory molecule RNAIII was able to suppress SpA gene transcription to the parental level in the sar mutant under inducible conditions, thus suggesting that the down-regulation in SpA gene transcription is partially mediated by RNAIII of the agr system. In studies with agr mutants (RN6911 and RN6112), our results showed that with increased sar dosage, SpA gene transcription can be suppressed to the parental level even in the absence of RNAIII. Additional studies with the double mutant ALC842 also revealed that SpA gene transcription can be down-modulated by supplying a plasmid carrying sar fragments. Taken together, our data support the hypothesis that the sar locus down-regulates SpA gene transcription via both agr-dependent and agr-independent but sar-specific pathways.
Interestingly, the agr mutant clone (ALC890 as derived from RN6911), as well as the double mutant clone (ALC891) containing an 819-bp DNA fragment (nucleotides 531 to 1349 according to the published sequence) (2) that comprised the sarA transcript together with a 189-bp upstream sequence, was successful in repressing SpA gene transcription to the parental level, while the respective clones expressing the sarA transcript alone did not alter the SpA gene transcript level. This genetic requirement contrasts with that seen in a sar mutant background, in which the sarA gene product alone was sufficient to down-regulate SpA gene transcription. This disparity in genetic requirements between agr and sar mutants for SpA suppression also concurs with the premise that there are two different modes of SpA repression by the sar locus.
Upon analysis of the sequence that spans the 189-bp region upstream of the sarA transcript, two structural features are apparent. First, this region encompasses a putative but weakly observed Shine-Dalgarno sequence that precedes a 39-aminoacid peptide coding region (ORF3 in Fig. 5) . Notably, the sar fragment in pALC888, as found in agr mutant and double mutant clones (ALC890 and ALC891), did not encompass the putative sarC-specific promoter. Nevertheless, we have not entirely ruled out the possibility that this peptide coding region is transcribed and translated as a result of adjacent active promoters within the shuttle vector. Clearly, additional studies must be done to assess the role of this peptide coding region in modulating SpA gene transcription. Second, the Shine-Dalgarno sequence of ORF3 overlaps with a 12-bp inverted repeat whose axis of symmetry lies 26 bp upstream of a possible (ATG) initiation codon ( Fig. 5) (2) . We have previously observed that a 5Ј deletion clone (pALC103) missing this particular inverted repeat resulted in a significant up-regulation in the sarA transcript, whereas a sar mutant clone encompassing this repeat but still lacking the sarC-specific promoter (ALC556) exhibited the parental level of sarA transcription (2) . Whether this inverted repeat may exercise a modulatory function in sarA transcription to influence SpA gene transcription indirectly is not certain. However, given that the sarA gene is required for SpA suppression, it is unlikely that this inverted repeat plays a dominant role in regulating SpA gene transcription because the sarA transcript containing only the sarA gene is overexpressed in the absence of this repeat. Although a single copy of the sarA gene was capable of suppressing SpA gene transcription in a sar mutant, this gene dosage was found to be insufficient for repression of SpA gene transcription in agr mutant bacteria grown in vitro because we have shown that the sar transcripts were expressed at parental levels in these mutants (Fig. 7) . For effective attenuation in SpA expression in an agr mutant background, our data appear to support the notion that the sar gene products may have to be augmented. Whether augmentation in selected sar gene products (e.g., sarC) will occur in vivo (e.g., in infected tissues) will not be known until similar studies are done on bacteria harvested directly from infected animals. Interestingly, we have recently observed that the spontaneous agr mutation leading to increased SpA production can occur upon routine subculture in blood agar plates (28) . Given that SpA is a major S. aureus cell wall protein that can make up as much as 7% of the cell wall content (12) , one can argue that it is unlikely that the organism will devote significant cellular resources to increasing the production of SpA at a time when SpA no longer confers survival advantages (e.g., antiphagocytic properties of SpA). The availability of sar to suppress protein A gene transcription in agr mutants may conserve bacterial resources, especially in situations where SpA expression is not needed (e.g., bacteria within abscesses not directly exposed to phagocytes).
Recently, we have reported the existence of a multiple promoter system within the sar locus (2). In particular, the middle promoter responsible for sarC transcription can also suppress protein A transcription in agr mutants (Fig. 5 and 6 ). This middle promoter has a sigma B-dependent promoter with 100% consensus with that of Bacillus subtilis at the Ϫ10 position. Sigma B promoters are generally activated in response to stress or in the postexponential phase of the growth cycle. In concordance with the finding in B. subtilis, our data revealed that the middle promoter is most active during the stationary phase (Fig. 7) . Preliminary reporter fusion studies showed that the middle promoter is active only upon sigma B induction in B. subtilis (unpublished data). Thus, it is theoretically plausible that increased sarC transcription in association with stress can occur in vivo to suppress protein A gene transcription in spontaneous agr mutants.
In a previous study, Vandenesch et al. showed that the provision of RNAIII in trans, preferentially expressed in the late log to stationary phase of the growth cycle, can repress SpA gene transcription in an agr mutant (26) . Remarkably, the transcription of the SpA gene, as discerned in this study, can also be repressed by RNAIII in the sar mutant background. Conversely, we also showed that in the agr mutant background, the down-modulation of SpA gene transcription would occur if the SpA gene transcript plus the essential upstream regulatory element are provided in trans (Fig. 5 and 6 ). The ability to curtail SpA gene transcription in either the sar or agr mutant background suggests that there are coregulatory factors in the capacity of S. aureus to down-regulate SpA expression in the stationary phase of the growth cycle. Whether sar or agr operates in different parts of the stationary growth cycle to regulate SpA gene transcription is not clear. Alternatively, the capacity for coregulation may provide the bacterium with the means to control SpA gene transcription in spontaneous agr or sar mutants. Notably, spontaneous agr mutants have been found on blood agar plates by selecting for ␣-hemolysin negative colonies (28) .
Based on recent gel shift data (15), we have hypothesized that the sar transcriptional elements are probably essential to the expression of DNA-binding proteins with binding specificity for the RNAII promoter, thereby activating RNAII and subsequently RNAIII transcription. We further suggested that the sar locus may control hemolysin production via the agrmediated pathway. However, the capacity to suppress SpA gene transcription with sar fragments in agr mutants lacking RNAIII transcription and vice versa implies that the sar-mediated pathway of SpA gene transcription has both RNAIII-dependent and RNAIII-independent components and thus differs from the sole RNAIII-dependent mechanism in the sar-mediated pathway of hemolysin production. This premise was supported by the finding that agr mutant clones containing plasmids including sarC or larger were able to repress SpA gene transcription but did not restore hemolysin production to these mutants (unpublished observation). Additionally, we cannot attribute the sar-mediated suppression of SpA gene transcription in agr mutants to possible counterregulation of sar by agr, because the sar transcripts were present at parental levels in an agr mutant (Fig. 7) .
During the growth cycle, SpA is actively synthesized during the log phase. However, the transcription of the SpA gene is repressed as the cells enter the late log to stationary phase of the growth cycle. The suppression of SpA gene transcription is coregulated by two repressor systems, agr and sar. Notably, the existence of coregulatory factors argues for a mechanism whereby the bacterial host can attenuate SpA gene transcription in different genetic backgrounds.
